Clinical Trial Update: Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a delayed-release pancrelipase for exocrine pancreatic insufficiency in cystic fibrosis patients has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Delayed-release pancrelipase (pancrelipase)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2009-07-20